Advertisement

Biomea Fusion, Inc. BMEA

Set alert

Price alert · BMEA

All alert types
0.64 USD +0.02 +2.68%

At close · Oct 30

0.65 +0.01 +1.49%

After hours · Oct 30, 7:39 PM ET

Bid
0.62 × 1
Ask
0.64 × 1
0.5901 Day range 0.6489
0.585 52-week range 2.21
YTD
-48.43%
1 year
-51.92%
Open
0.63
Prev close
0.6228
Mkt cap
46.35M
Vol
1.11M
Avg vol
2.12M
EPS
-0.29
P/E
0.00
Div yield
0.00%
More statistics
Low
0.5901
High
0.6489
Forward P/E
-1.21
Beta
-0.43
Short ratio
12.98
Inst. own
64.56%
Dividend
0.00
Ex-div date
Earnings
Jul 31, 2024
50-d avg
7.91
200-d avg
8.85
1y target
40.56

1D chart

Chart tools
Interval

Signals (93)
NameTimeAgo
SMA: Bullish4:00 PM2 days ago
SMA: Bearish3:57 PM2 days ago
MACD: Sell Signal3:57 PM2 days ago
MACD: Buy Signal3:54 PM2 days ago
SMA: Bullish3:49 PM2 days ago
SMA: Bearish3:47 PM2 days ago
SMA: Bullish3:45 PM2 days ago
SMA: Bearish3:44 PM2 days ago
MACD: Sell Signal3:35 PM2 days ago
SMA: Bullish3:15 PM2 days ago
SMA: Bullish3:15 PM2 days ago
SMA: Bearish3:14 PM2 days ago
SMA: Bearish3:14 PM2 days ago
SMA: Bullish3:12 PM2 days ago
SMA: Bullish3:12 PM2 days ago
SMA: Bearish3:11 PM2 days ago
SMA: Bearish3:11 PM2 days ago
SMA: Bullish3:10 PM2 days ago
SMA: Bullish3:10 PM2 days ago
SMA: Bearish3:09 PM2 days ago
SMA: Bearish3:09 PM2 days ago
SMA: Bullish3:08 PM2 days ago
SMA: Bullish3:08 PM2 days ago
SMA: Bearish3:00 PM2 days ago
SMA: Bearish3:00 PM2 days ago
SMA: Bullish2:59 PM2 days ago
SMA: Bullish2:59 PM2 days ago
SMA: Bearish2:50 PM2 days ago
SMA: Bullish2:49 PM2 days ago
SMA: Bearish2:37 PM2 days ago
SMA: Bullish2:33 PM2 days ago
MACD: Buy Signal2:30 PM2 days ago
RSI: Oversold2:18 PM2 days ago
RSI: Oversold2:05 PM2 days ago
SMA: Bearish1:53 PM2 days ago
SMA: Bullish1:52 PM2 days ago
SMA: Bullish1:48 PM2 days ago
SMA: Bearish1:46 PM2 days ago
SMA: Bullish1:45 PM2 days ago
SMA: Bearish1:43 PM2 days ago
SMA: Bearish1:43 PM2 days ago
MACD: Sell Signal1:30 PM2 days ago
MACD: Buy Signal1:15 PM2 days ago
SMA: Bullish1:11 PM2 days ago
SMA: Bullish1:11 PM2 days ago
SMA: Bearish1:10 PM2 days ago
SMA: Bearish1:10 PM2 days ago
MACD: Sell Signal1:10 PM2 days ago
MACD: Buy Signal12:56 PM2 days ago
SMA: Bullish12:50 PM2 days ago
SMA: Bearish12:45 PM2 days ago
SMA: Bullish12:40 PM2 days ago
SMA: Bearish12:39 PM2 days ago
SMA: Bullish12:34 PM2 days ago
SMA: Bearish12:33 PM2 days ago
MACD: Sell Signal12:30 PM2 days ago
RSI: Overbought12:20 PM2 days ago
SMA: Bullish12:15 PM2 days ago
SMA: Bullish12:15 PM2 days ago
SMA: Bearish12:07 PM2 days ago
SMA: Bearish12:07 PM2 days ago
SMA: Bullish12:05 PM2 days ago
SMA: Bullish12:05 PM2 days ago
SMA: Bearish12:04 PM2 days ago
SMA: Bearish12:04 PM2 days ago
SMA: Bullish12:03 PM2 days ago
SMA: Bullish12:03 PM2 days ago
MACD: Buy Signal12:03 PM2 days ago
SMA: Bearish11:47 AM2 days ago
SMA: Bearish11:47 AM2 days ago
SMA: Bullish11:46 AM2 days ago
SMA: Bearish11:37 AM2 days ago
MACD: Sell Signal11:37 AM2 days ago
SMA: Bullish11:33 AM2 days ago
MACD: Buy Signal11:33 AM2 days ago
SMA: Bearish11:31 AM2 days ago
MACD: Sell Signal11:31 AM2 days ago
MACD: Buy Signal11:04 AM2 days ago
SMA: Bullish11:03 AM2 days ago
SMA: Bullish11:00 AM2 days ago
SMA: Bearish10:59 AM2 days ago
SMA: Bullish10:57 AM2 days ago
MACD: Sell Signal10:56 AM2 days ago
SMA: Bearish10:55 AM2 days ago
SMA: Bearish10:54 AM2 days ago
SMA: Bullish10:53 AM2 days ago
SMA: Bearish10:52 AM2 days ago
SMA: Bullish10:42 AM2 days ago
SMA: Bullish10:33 AM2 days ago
SMA: Bearish10:32 AM2 days ago
SMA: Bullish10:30 AM2 days ago
SMA: Bearish10:10 AM2 days ago
SMA: Bullish10:09 AM2 days ago

Key statistics

Market cap
145.32M
Enterprise value
74.90M
Trailing P/E
0.00
Forward P/E
-1.21
PEG ratio
0.00
Price / sales
0.00
Price / book
1.91
EPS (TTM)
-4.01
Beta
-0.43
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
-65.44M
Total cash
87.95M
Total debt
9.57M
Return on equity
-104.51%
Shares outstanding
36.24M
Short % of float
44.56%
50-day average
7.91
200-day average
8.85

Analyst view

Consensus: buy

Buy
Price target (mean) 40.56 +6241.8% upside
Target (low)
11.00
Target (mean)
40.56
Target (high)
128.00
Ratings (0m) 9 7 buy · 2 hold · 0 sell
  • Strong buy3
  • Buy4
  • Hold2
  • Sell0
  • Strong sell0

Next earnings

Jul 31, 2024

Expected Jul 31, 2024. Consensus EPS estimate -0.92933.

Earnings history

Financials — quick view

All financials
BMEA Revenue — quarterly 0
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
BMEA Net income — quarterly -8.33M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
BMEA EPS — quarterly -0.12
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

BMEA recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Oct 29, 2024Sep 1, 2024-1.05-0.91+0.14+13.33%
Jul 31, 2024Jun 1, 2024-1.03-1.030.000.00%
Jul 31, 2024Jun 1, 2024-1.03———
May 2, 2024Mar 1, 2024-1.02-1.09-0.07-6.86%
May 2, 2024Mar 1, 2024-1.02———
Apr 1, 2024Dec 1, 2023-0.85-0.98-0.13-15.29%

Upgrades / downgrades

BMEA analyst upgrades and downgrades
DateFirmActionFromTo
Dec 19, 2024D. Boral CapitalmainBuyBuy
Dec 18, 2024HC Wainwright & Co.reitBuyBuy
Dec 17, 2024D. Boral CapitalmainBuyBuy
Dec 16, 2024HC Wainwright & Co.reitBuyBuy
Dec 10, 2024D. Boral CapitalmainBuyBuy
Dec 10, 2024HC Wainwright & Co.reitBuyBuy

About Biomea Fusion, Inc.

Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, a covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. The company was incorporated in 2017 and is headquartered in Redwood City, California.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

Your note

Sign in to keep a note on BMEA — it syncs with the Stock Master app.

Insider holders

BMEA insider holders
InsiderRelationLatest transactionDateShares held
A2A PHARMACEUTICALS INCBeneficial Owner of more than 10% of a Class of SecuritySaleMay 31, 20233,500,000
CHEN BIHUA X.Director and Beneficial Owner of more than 10% of a Class of SecurityPurchaseMar 29, 20230
ERDTMANN RAINER MPresidentStock GiftDec 28, 20232,532,820
FRIAS JUAN PABLOOfficerStock Award(Grant)May 30, 2024349
HITCHCOCK MICHAEL J.M.DirectorPurchaseSep 29, 202415,000
VALLE FRANCOChief Financial OfficerStock Award(Grant)Nov 28, 202442,995

Institution ownership

BMEA institution ownership
Holder% heldSharesValueReported
FMR, LLC14.99%5,431,52521.78MSep 29, 2024
Cormorant Asset Management, LP9.85%3,570,87214.32MSep 29, 2024
Blackrock Inc.6.34%2,296,5939.21MSep 29, 2024
Baker Bros. Advisors, LP5.82%2,108,9498.46MSep 29, 2024
Vanguard Group Inc3.86%1,397,8975.61MSep 29, 2024
Millennium Management Llc3.80%1,378,4085.53MSep 29, 2024

Fund ownership

BMEA fund ownership
Holder% heldSharesValueReported
Fidelity Growth Company Fund4.49%1,625,8376.52MOct 30, 2024
iShares Russell 2000 ETF1.98%718,8682.88MOct 30, 2024
Vanguard Total Stock Market Index Fund1.96%711,7732.85MSep 29, 2024
Fidelity Growth Company K6 Fund1.71%620,2002.49MOct 30, 2024
Fidelity Series Growth Company Fund1.44%520,4272.09MOct 30, 2024
Fidelity Select Portfolios - Biotechnology1.08%392,1291.57MOct 30, 2024
Advertisement